Lymphatic vasculature: Dermatological implications of emerging concepts;Le système vasculaire lymphatique : états des connaissances et implications dermatologiques potentielles

Annales de Dermatologie et de Venereologie

Volumn 135, Issue 10, 2008, Pages 704-709

  Henno, A ^a,b   Lapiere C M ^b   Nusgens, B V ^b   de la Brassinne, M ^b  

^a Aspirante FNRS ^*  (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ARTICLE; EMBRYO DEVELOPMENT; HUMAN; INFLAMMATION; KAPOSI SARCOMA; LYMPH FLOW; LYMPHANGIOGENESIS; LYMPHEDEMA; METASTASIS; SKIN CANCER; VASCULARIZATION; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM; LYMPHATIC SYSTEM DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY;

HUMANS; LYMPHANGIOGENESIS; LYMPHATIC DISEASES; LYMPHATIC METASTASIS; LYMPHATIC SYSTEM;

EID: 58149186081     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annder.2008.04.013     Document Type: Article

References (29)

1. Hong Y.K., Lange-Asschenfeldt B., Velasco P., Hirakawa S., Kunstfeld R., Brown L.F., et al. VEGF-A promotes tissue-repair-associated lymphatic vessel formation via VEGFR2 and the α1β1 and α2β1 integrins. FASEB J 18 (2004) 1111-1113
2. Alitalo K., Tammela T., and Petrova T.V. Lymphangiogenesis in development and human disease. Nature 438 (2005) 946-953
3. Karkkainen M.J., Haiko P., Sainio K., Partanen J., Taipale J., Petrova T.V., et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5 (2004) 74-80
4. Jeltsch M., Kaipainen A., Joukov V., Meng X., Lakso M., Rauvala H., et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276 (1997) 1423-1425 Erratum in Science 1997, 277:463
5. Partanen T.A., Arola J., Saaristo A., Jussila L., Ora A., Miettinen M., et al. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J 14 (2000) 2087-2096
6. Kubo H., Fujiwara T., Jussila L., Hashi H., Ogawa M., Shimizu K., et al. Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood 96 (2000) 546-553
7. Saaristo A., Karkkainen M., and Alitalo K. Insights into the molecular pathogenesis and targeted treatment of lymphoedema. Ann N Y Acad Sci 979 (2002) 94-110
8. Baldwin M., Halford M., Roufail S., Williams R., Hibbs M., Grail D., et al. Vascular endothelial growth factor-D is dispensable for development of the lymphatic system. Mol Cell Biol 25 (2005) 2441-2449
9. Saharinen P., Tammela T., Karkkainen M., and Alitalo K. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 25 (2004) 387-395
10. Banerji S., Ni J., Wang S., Clasper S., Su J., Tammi R., et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144 (1999) 789-801
11. Rutkowski J.M., Boardman K.C., and Swartz M.A. Characterization of lymphangiogenesis in a model of adult skin regeneration. Am J Physiol Heart Circ Physiol 291 (2006) H1402-H1410
12. Lazareth I. Classification des lymphœdèmes. Rev Med Interne 23 (2002) 375s-378s
13. Rockson S. Lymphoedema. Am J Med 110 (2001) 288-295
14. Karkkainen M., Jussila L., Ferrell R., Finegold D., and Alitalo K. Molecular regulation of lymphangiogenesis and targets for tissue oedema. Trends Mol Med 7 (2001) 18-22
15. Karkkainen M.J., Saaristo A., Jussila L., Karila K.A., Lawrence E.C., Pajusola K., et al. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci U S A 98 (2001) 12677-12682
16. Petrova T.V., Karpanen T., Norrmen C., Mellor R., Tamakoshi T., Finegold D., et al. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphoedema distichiasis. Nat Med 10 (2004) 974-981
17. Ruocco V., Schwartz R., and Ruocco E. Lymphedema: an immunologically vulnerable site for development of neoplasms. J Am Acad Dermatol 47 (2002) 124-127
18. Szuba A., Skobe M., Karkkainen M., Shin W., Beynet D., Rockson N., et al. Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J 16 (2002) 1985-1987
19. Dadras S.S., Lange-Asschenfeld B., Velasco P., Nguyen L., Vora A., Muzikansky A., et al. Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol 18 (2005) 1232-1242
20. Maula S.M., Luukkaa M., Grenman R., Jackson D., Jalkanen S., and Ristamaki R. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res 63 (2003) 1920-1926
21. Mandriota S.J., Jussila L., Jeltsch M., Compagni A., Baetens D., Prevo R., et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20 (2001) 672-682
22. Straume O., and Akslen L.A. Lymphatic vessel density and prognosis in cutaneous melanoma. Br J Cancer 91 (2004) 1224-1225
23. Gallo R. The enigma of Kaposi's sarcoma. Science 282 (1998) 1837-1839
24. Reitz M., Nerurkar L., and Gallo R. Perspective on Kaposi's sarcoma: facts, concepts and conjectures. J Natl Cancer Inst 91 (1999) 1453-1458
25. Dupin N., and Calvez V. Virus HHV-8/KSHV. I- Aspects épidémiologiques et moléculaires. Ann Dermatol Venereol 127 (2000) 528-531
26. Wang H., Trotter M., Lagos D., Bourboulia D., Henderson S., Mäkinen T., et al. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 36 (2004) 687-693
27. Hong Y., Foreman K., Shin J., Hirakawa S., Curry C., Sage D., et al. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet 36 (2004) 683-685
28. Kajiya K., and Detmar M. An important role of lymphatic vessels in the control of UVB-induced edema formation and inflammation. J Invest Dermatol 126 (2006) 919-921
29. Henno A., Lapière C.M., de la Brassinne M., and Nusgens B. The expression of angiogenesis and lymphangiogenesis markers is higher in normal skin of psoriatic patients than in healthy volunteer skin. J Invest Dermatol 126 (2006) S3-S99 [abstract]